AHA Scientific Statement: Advancing Precision Medicine in Cardio-Oncology with AI
February 24, 2025
A newly published scientific statement from the American Heart Association (AHA), titled "Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology," explores the transformative potential of artificial intelligence (AI) in predicting and managing cardiovascular risks in cancer patients. With the increasing use of immune checkpoint inhibitors (ICIs) and targeted therapies, cardio-oncology faces the challenge of identifying…
All Things Cardio-Oncology Podcast w/ Dr. Alexi Vasbinder
September 23, 2024
Join Dr. Vasbinder on the All Things Cardio-Oncology Podcast hosted by the International Cardio-Oncology Society where she unpacks the cardiovascular risks that can emerge following a stem cell transplant. In this insightful discussion, Dr. Vasbinder explains the underlying mechanisms that elevate CV risk post-transplant, outlines key risk factors to watch for, and explores strategies for…